• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症的症状学:来自德国多发性硬化症登记处的结果。

Symptomatology of MS: results from the German MS Registry.

出版信息

J Neurol. 2009 Nov;256(11):1932-5. doi: 10.1007/s00415-009-5257-5. Epub 2009 Jul 23.

DOI:10.1007/s00415-009-5257-5
PMID:19629565
Abstract

Since 2002, an MS Registry has been implemented by the German MS Society in more than 100 German MS centres. The objective is to provide information about disease characteristics, and to monitor the health care situation in a large population of patients. The aim of this report is to give detailed results on MS symptoms. By October 2008, data sets from 16,554 patients were recorded by 86 centres. A strikingly high number of persons suffered from fatigue and other "invisible" symptoms during early and late stages of the disease, underscoring the negative impact of these symptoms on quality of life in MS patients.

摘要

自 2002 年以来,德国多发性硬化症协会在 100 多个德国多发性硬化症中心实施了多发性硬化症登记处。其目的是提供有关疾病特征的信息,并监测大量患者的医疗保健状况。本报告的目的是详细介绍多发性硬化症症状的结果。截至 2008 年 10 月,86 个中心共记录了 16554 名患者的数据。在疾病的早期和晚期,有大量的人患有疲劳和其他“无形”症状,这突显了这些症状对多发性硬化症患者生活质量的负面影响。

相似文献

1
Symptomatology of MS: results from the German MS Registry.多发性硬化症的症状学:来自德国多发性硬化症登记处的结果。
J Neurol. 2009 Nov;256(11):1932-5. doi: 10.1007/s00415-009-5257-5. Epub 2009 Jul 23.
2
National MS registries.国家多发性硬化症登记处。
J Neurol. 2008 Dec;255 Suppl 6:102-8. doi: 10.1007/s00415-008-6019-5.
3
Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry.多发性硬化症长期数据存储库的机遇与挑战:德国多发性硬化症注册处 20 周年。
Sci Rep. 2021 Jun 25;11(1):13340. doi: 10.1038/s41598-021-92722-x.
4
[MS registry in Germany--design and first results of the pilot phase].[德国的多发性硬化症登记系统——试点阶段的设计与初步结果]
Nervenarzt. 2005 Aug;76(8):967-75. doi: 10.1007/s00115-005-1907-8.
5
[Data on multiple sclerosis in Germany and their representation in the ambulatory registry NeuroTransData (NTD) network].[德国多发性硬化症数据及其在门诊登记处神经传输数据(NTD)网络中的呈现]
Fortschr Neurol Psychiatr. 2020 Jun;88(6):379-385. doi: 10.1055/a-1130-6222. Epub 2020 Jun 18.
6
Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.多发性硬化症的对症治疗——一项全国性登记研究的中期分析
Acta Neurol Scand. 2017 Apr;135(4):394-399. doi: 10.1111/ane.12612. Epub 2016 Jun 9.
7
[Multiple sclerosis in Germany: updated analysis of the German MS Registry 2014-2018].[德国的多发性硬化症:德国多发性硬化症注册中心2014 - 2018年的最新分析]
Fortschr Neurol Psychiatr. 2020 Jul;88(7):436-450. doi: 10.1055/a-0985-4124. Epub 2020 Jul 27.
8
The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey.多发性硬化症相关症状与残疾和生活质量的关联:一项丹麦大型自我报告调查。
BMC Neurol. 2021 Aug 16;21(1):317. doi: 10.1186/s12883-021-02344-z.
9
Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.多发性硬化症的疲劳特征:北美多发性硬化症研究委员会(NARCOMS)调查
Health Qual Life Outcomes. 2008 Nov 14;6:100. doi: 10.1186/1477-7525-6-100.
10
[Quality of life and care of members of the Saxonian branch of the German Society for Multiple Sclerosis. Results of a written questionnaire].[德国多发性硬化症协会萨克森州分会成员的生活质量与护理。一份书面调查问卷的结果]
Gesundheitswesen. 2007 Aug-Sep;69(8-9):457-63. doi: 10.1055/s-2007-985866.

引用本文的文献

1
MS treatment trends before, during, and after the COVID-19 pandemic: insights from the German MS Register.新冠疫情之前、期间及之后的多发性硬化症治疗趋势:来自德国多发性硬化症登记处的见解
J Neurol. 2025 Mar 26;272(4):294. doi: 10.1007/s00415-025-13010-6.
2
Perceived discrimination in fatigue: a qualitative interview study in the SOMA.SOC project.疲劳方面的感知歧视:SOMA.SOC项目中的一项定性访谈研究
Front Sociol. 2025 Feb 5;10:1528312. doi: 10.3389/fsoc.2025.1528312. eCollection 2025.
3
Fatigue in multiple sclerosis: A scoping review of pharmacological and nonpharmacological interventions.

本文引用的文献

1
National MS registries.国家多发性硬化症登记处。
J Neurol. 2008 Dec;255 Suppl 6:102-8. doi: 10.1007/s00415-008-6019-5.
2
Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.多发性硬化症的基础及逐步升级的免疫调节治疗:当前治疗建议
J Neurol. 2008 Oct;255(10):1449-63. doi: 10.1007/s00415-008-0061-1. Epub 2008 Oct 29.
3
[MS registry in Germany--design and first results of the pilot phase].[德国的多发性硬化症登记系统——试点阶段的设计与初步结果]
多发性硬化症中的疲劳:药物和非药物干预的范围综述
Mult Scler J Exp Transl Clin. 2025 Feb 13;11(1):20552173241312527. doi: 10.1177/20552173241312527. eCollection 2025 Jan-Mar.
4
Early comorbidities and diagnostic challenges in people with multiple sclerosis with possible impact on disease management.多发性硬化症患者的早期合并症及诊断挑战,可能对疾病管理产生影响。
Mult Scler J Exp Transl Clin. 2025 Feb 12;11(1):20552173251315458. doi: 10.1177/20552173251315458. eCollection 2025 Jan-Mar.
5
Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry.多发性硬化症患者疾病修饰疗法的治疗转换:来自德国多发性硬化症注册中心的长期经验。
Ther Adv Neurol Disord. 2024 Mar 29;17:17562864241239740. doi: 10.1177/17562864241239740. eCollection 2024.
6
Side effects following vaccination in multiple sclerosis: a prospective, multi-centre cohort study.接种疫苗后多发性硬化症的副作用:一项前瞻性、多中心队列研究。
Sci Rep. 2023 Sep 2;13(1):14480. doi: 10.1038/s41598-023-41271-6.
7
The pathophysiology of motor fatigue and fatigability in multiple sclerosis.多发性硬化症中运动疲劳和易疲劳性的病理生理学。
Front Neurol. 2022 Jul 27;13:891415. doi: 10.3389/fneur.2022.891415. eCollection 2022.
8
Impact of Lockdown during COVID-19 Pandemic on Central Activation, Muscle Activity, Contractile Function, and Spasticity in People with Multiple Sclerosis.COVID-19 大流行期间封锁对多发性硬化症患者中枢激活、肌肉活动、收缩功能和痉挛的影响。
Biomed Res Int. 2021 Oct 21;2021:2624860. doi: 10.1155/2021/2624860. eCollection 2021.
9
Patients and Partners in Research: Patient and Caregiver Perceptions of Research Engagement and the Role of Their Psychosocial States in Participation.研究中的患者与伙伴:患者及照料者对研究参与的认知及其社会心理状态在参与过程中的作用
J Patient Exp. 2021 Jun 22;8:23743735211018084. doi: 10.1177/23743735211018084. eCollection 2021.
10
The Effect of Depression on Health-Related Quality of Life Is Mediated by Fatigue in Persons with Multiple Sclerosis.抑郁症对多发性硬化症患者健康相关生活质量的影响是通过疲劳介导的。
Brain Sci. 2021 Jun 5;11(6):751. doi: 10.3390/brainsci11060751.
Nervenarzt. 2005 Aug;76(8):967-75. doi: 10.1007/s00115-005-1907-8.
4
Treatment patterns of multiple sclerosis patients: a comparison of veterans and non-veterans using the NARCOMS registry.多发性硬化症患者的治疗模式:使用NARCOMS登记系统对退伍军人和非退伍军人的比较
Mult Scler. 2005 Feb;11(1):33-40. doi: 10.1191/1352458505ms1136oa.
5
Change in MS-related disability in a population-based cohort: a 10-year follow-up study.基于人群队列的多发性硬化症相关残疾变化:一项10年随访研究。
Neurology. 2004 Jan 13;62(1):51-9. doi: 10.1212/01.wnl.0000101724.93433.00.
6
Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.界定多发性硬化症的临床病程:一项国际调查结果。美国国家多发性硬化症协会新型药物治疗多发性硬化症临床试验咨询委员会
Neurology. 1996 Apr;46(4):907-11. doi: 10.1212/wnl.46.4.907.
7
Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted County, Minnesota.多发性硬化症中的损伤、残疾和障碍:明尼苏达州奥尔姆斯特德县的一项基于人群的研究。
Neurology. 1994 Jan;44(1):28-33. doi: 10.1212/wnl.44.1.28.
8
The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.多发性硬化症的自然史:一项基于地域的研究。I. 临床病程与残疾情况
Brain. 1989 Feb;112 ( Pt 1):133-46. doi: 10.1093/brain/112.1.133.